GENECENTRIC THERAPEUTICS, INC.; INC.;GENECENTRIC THERAPEUTICS;THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
发明人:
FARUKI, HAWAZIN,LAI-GOLDMAN, MYLA,MAYHEW, GREG,SERODY, JONATHAN,PEROU, CHARLES,HAYES, DAVID NEIL
申请号：
CA3024747
公开号：
CA3024747A1
申请日:
2017.05.17
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
Methods and compositions are provided for determining a subtype of lung adenocarcinoma (AD) of an individual by detecting the expression level of at least one classifier biomarker selected from a group of gene signatures for lung adenocarcinoma. Also provided herein are methods and compositions for determining the response of an individual with an adenocarcinoma subtype to a therapy such as immunotherapy.
